Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Merck’s first microbiology application and training lab in India
With this, the company can start selling Ibuprofen in the European markets.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Subscribe To Our Newsletter & Stay Updated
